Literature DB >> 18413622

Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies.

Kimberly A Workowski1, Stuart M Berman, John M Douglas.   

Abstract

Prevention and control of gonorrhea is an important public health concern due to the high burden of disease, the recent increase in reported infection rates, and the reproductive and economic consequences of infection. Effective antibiotic treatment is one essential component of an integrated approach to gonorrhea control. Over the past 60 years, however, development of resistance in Neisseria gonorrhoeae to multiple antimicrobial classes challenges this component of gonorrhea control. An integrated, comprehensive prevention strategy should include enhancement of national and international surveillance systems to monitor antimicrobial resistance and new strategies to maximize the benefit and prolong the utility of antimicrobials, including combination regimens, implementation of screening recommendations for individuals at high risk for infection, and the assurance of prompt and effective treatment for infected persons and their sexual partners. Progress in controlling the epidemic and avoiding a resurgence as treatment options wane will require careful attention to all components of a comprehensive prevention strategy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413622     DOI: 10.7326/0003-4819-148-8-200804150-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  49 in total

Review 1.  The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.

Authors:  Juliet E Stoltey; Pennan M Barry
Journal:  Expert Opin Pharmacother       Date:  2012-05-30       Impact factor: 3.889

2.  Purification and biochemical characterization of DnaK and its transcriptional activator RpoH from Neisseria gonorrhoeae.

Authors:  Shalini Narayanan; Simone A Beckham; John K Davies; Anna Roujeinikova
Journal:  Mol Biol Rep       Date:  2014-08-26       Impact factor: 2.316

3.  Multidrug-resistant Neisseria gonorrhoeae.

Authors:  John Tapsall
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

4.  MtrR modulates rpoH expression and levels of antimicrobial resistance in Neisseria gonorrhoeae.

Authors:  Jason P Folster; Paul J T Johnson; Lydgia Jackson; Vijaya Dhulipali; David W Dyer; William M Shafer
Journal:  J Bacteriol       Date:  2008-10-31       Impact factor: 3.490

5.  Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak.

Authors:  Sheldon R Morris; Douglas F Moore; Paul B Hannah; Susan A Wang; Julia Wolfe; David L Trees; Gail Bolan; Heidi M Bauer
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

6.  Successful treatment of uncomplicated gonococcal urethritis in HIV-infected patients with single-dose oral cefpodoxime.

Authors:  George Psevdos; Victoria Sharp
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

7.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

8.  Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae.

Authors:  Hsi Liu; Thomas H Taylor; Kevin Pettus; David Trees
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

9.  Gonococcal cellulitis: an (un)friendly bite.

Authors:  Amos Lal; Alwyn Rapose
Journal:  Infection       Date:  2018-03-16       Impact factor: 3.553

10.  In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.

Authors:  Lindley A Barbee; Olusegun O Soge; King K Holmes; Matthew R Golden
Journal:  J Antimicrob Chemother       Date:  2014-01-26       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.